See Omada Health press releases and coverage activity.
Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its second quarter 2025 results.
Read Article
New GLP-1 analysis reveals that by addressing real-world barriers to persistence, Omada’s companion program can help sustain GLP-1 use, delivering on clinical trials' promises
Read Article
Error - something went wrong!
Stay up to date with Omada
news
Thank you!
Omada Health, the virtual between-visit healthcare provider, today announced the pricing of its initial public offering of 7,900,000 shares of its common stock, at a public offering price of $19.00 pe
Read Article
Omada Health announces its initial public offering, offering 7.9 million shares at $18–$20 each, and plans to list on Nasdaq under the ticker symbol “OMDA.”
Read Article
Introducing Omada Health's Nutritional Intelligence with AI-powered OmadaSpark! Experience real-time support to tackle emotional eating & make informed, lasting food choices for a healthier lifestyle
Read Article
Omada Health presented three posters at the Society of Behavioral Medicine's Annual Meeting. New data demonstrates behavioral, mental, and physical health benefits of Omada's cardiometabolic programs.
Read Article
Omada’s Clinical Advisory Board demonstrates its commitment to rigorous clinical evaluation and helps underscore the impact of its behavior change programs
Read Article
In a survey of over 2,000 doctors, a majority believed GLP-1s need to be paired with changes in diet and exercise to be effective in driving healthy weight loss.
Read Article
Real-world data analysis shows Omada members, on average, experienced virtually no weight gain 16 weeks after discontinuing a GLP-1 compared to an average of 6-7% weight gain estimated from trial data
Read Article
Survey finds only 18% of respondents who discontinued GLP-1s achieved their weight loss goals; respondents want to lose an average of 22% more weight.
Read Article
Dr. Beal brings extensive experience in clinical innovation, patient advocacy, and population health to Omada’s Board.
Read Article
Through Alaska’s Fresh Start Campaign, Thousands of Residents Have Access to Omada’s Virtual Prevention, Diabetes, and Hypertension Coaching Programs
Read Article
Error - something went wrong!
Stay up to date with Omada
news
Thank you!
New board members provide deep clinical and commercial experience.
Read Article
Company pledges to keep humans at the center of care.
Read Article
Omada Health, the virtual-first healthcare provider, published its 28th peer-reviewed study demonstrating the long-term outcomes of utilizing a behavior change program for members with type 2 diabetes
Read Article
Findings show that meaningfully engaged Omada members on GLP-1s achieved an average of 1.7 times greater weight loss, and inform a new collaboration with Evernorth's EncircleRx program.
Read Article
Building on more than a decade of insights and 28 peer-reviewed publications, Omada announces plans to develop more learnings focused on the long-term outcomes of GLP-1s on weight health
Read Article
Omada Health Enhances GLP-1 Care Track to Support Customers Managing Medications and Integrates MSK Support.
Read Article
The new offering will make it easier for Omada’s over 20 million eligible members to discover and enroll in Omada’s cardiometabolic programs.
Read Article
Omada’s innovative member-to-provider virtual MSK program meets the industry’s top clinical standards with URAC accreditation for telehealth
Read Article
Loading More...
